DroneShield's Two-Front War: Global Banks Accumulate While Short Sellers Circle at 15%

Global banks raise stakes in DroneShield while short interest hits 15%, as stock trades 70% below highs amid CEO share sale and product launch.

The Australian counter-drone specialist is living a contradiction. International banking heavyweights Citigroup and JPMorgan Chase have quietly built out their stakes in DroneShield over the past week, yet the stock remains one of the most heavily shorted names on the Australian market — with bearish positions sitting at 15 percent, according to ASIC data released Monday. Only Lotus Resources, at 17.2 percent, carries a heavier short load.

That juxtaposition captures the tension animating the stock right now. Institutional money is flowing in at the same time short sellers are pressing their bets, leaving the share price caught between competing narratives of conviction and caution.

A Share Price Still Nursing Wounds

The bearish case has been reinforced by recent price action. The stock closed Friday at EUR 1.13, down 3.9 percent on the day and well below its 50-day moving average of EUR 1.37 — a technical signal that the medium-term trend remains pointed downward. Over the past month the shares have shed 11 percent, and at current levels they sit roughly 70 percent beneath the 52-week high reached on October 1.

The damage traces back to a one-two punch that rattled investor confidence: a share sale by the company's chief executive followed by the withdrawal of a corporate announcement. For market participants, that combination reads as a classic warning sign, and it has helped fuel the elevated short interest. The episode underscores how quickly trust can erode at the market level, even when the underlying business continues to grow.

Heavyweights Move In

Against that unsettled backdrop, the regulatory filings from Citigroup and JPMorgan stand out. Citigroup crossed the 5 percent disclosure threshold in early August, with its filing dated August 7. JPMorgan Chase had increased its position just days earlier, on August 4. Both disclosures landed in the same week DroneShield unveiled RfRecon, its new portable radio-frequency reconnaissance system designed for drone defense.

To be sure, these filings are mandatory regulatory notices rather than outright endorsements. But the near-simultaneous accumulation by two global financial institutions is being read by some observers as a vote of confidence in the company's medium-term growth story — even as the share price keeps sliding. Whether that signals contrarian positioning ahead of a stabilization, or simply reflects institutional portfolio mechanics, remains an open question.

Product Pipeline and the Numbers Behind It

The product news itself has yet to move the needle. Since RfRecon's unveiling roughly two weeks ago, the stock has given back 6.1 percent, suggesting the market is waiting for commercial proof before pricing in the new system's potential. DroneShield says it has begun initial conversations with qualified customers across defense, government and security agencies worldwide, with first orders anticipated in the second half of 2026.

The company also delivered its interim results yesterday, confirming full-year revenue guidance of AUD 250 million to AUD 270 million after booking AUD 125.8 million in the first half. Management's investor materials reportedly touched on gross margin development as well, though the details remain under review by analysts.

What Happens Next

With short interest at 15 percent, the stock remains vulnerable to sharp moves in either direction. Should DroneShield manage to address the communication and leadership concerns that have weighed on sentiment, positive operational news could trigger a short squeeze. Until then, the shares look likely to stay hostage to the volatility that has defined recent months.

For investors, the picture is split down the middle: two prestigious international houses are adding exposure while the share price languishes below its key moving averages. The resolution may only come in the months ahead, when the first concrete orders tied to RfRecon either validate the institutional optimism or confirm the skeptics' caution.